Thermo Fisher Scientific Inc. [NYSE: TMO] surged by $16.7 during the normal trading session on Thursday and reaching a high of $465.695 during the day while it closed the day at $464.91. The company report on June 9, 2021 that Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT).
You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com.
Thermo Fisher Scientific Inc. stock has also gained 4.40% of its value over the past 7 days. However, TMO stock has inclined by 0.95% in the 3 months of the year. Over the past six months meanwhile, it has lost -1.91% and lost -0.19% year-on date.
The market cap for TMO stock reached $181.32 billion, with 394.00 million shares outstanding and 392.22 million shares in the current float. Compared to the average trading volume of 1.79M shares, TMO reached a trading volume of 2679026 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Thermo Fisher Scientific Inc. [TMO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TMO shares is $558.08 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TMO stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
KeyBanc Capital Markets have made an estimate for Thermo Fisher Scientific Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 18, 2021. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on March 03, 2021, representing the official price target for Thermo Fisher Scientific Inc. stock. Previously, the target price had yet another raise from $490 to $556, while Credit Suisse kept a Outperform rating on TMO stock. On December 16, 2020, analysts decreased their price target for TMO shares from 550 to 500.
The Average True Range (ATR) for Thermo Fisher Scientific Inc. is set at 9.60, with the Price to Sales ratio for TMO stock in the period of the last 12 months amounting to 5.05. The Price to Book ratio for the last quarter was 5.22, with the Price to Cash per share for the same quarter was set at 14.62. Price to Free Cash Flow for TMO in the course of the last twelve months was 23.51 with Quick ratio for the last quarter at 1.90.
TMO stock trade performance evaluation
Thermo Fisher Scientific Inc. [TMO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.40. With this latest performance, TMO shares gained by 0.20% in over the last four-week period, additionally sinking by -1.91% over the last 6 months – not to mention a rise of 31.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TMO stock in for the last two-week period is set at 54.11, with the RSI for the last a single of trading hit 58.89, and the three-weeks RSI is set at 51.85 for Thermo Fisher Scientific Inc. [TMO]. The present Moving Average for the last 50 days of trading for this stock 467.27, while it was recorded at 449.47 for the last single week of trading, and 465.59 for the last 200 days.
Thermo Fisher Scientific Inc. [TMO]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Thermo Fisher Scientific Inc. [TMO] shares currently have an operating margin of +24.60 and a Gross Margin at +49.75. Thermo Fisher Scientific Inc.’s Net Margin is presently recorded at +19.79.
Return on Total Capital for TMO is now 15.07, given the latest momentum, and Return on Invested Capital for the company is 12.55. Return on Equity for this stock inclined to 19.87, with Return on Assets sitting at 10.01. When it comes to the capital structure of this company, Thermo Fisher Scientific Inc. [TMO] has a Total Debt to Total Equity ratio set at 65.33. Additionally, TMO Total Debt to Total Capital is recorded at 39.52, with Total Debt to Total Assets ending up at 32.65. Long-Term Debt to Equity for the company is recorded at 57.19, with the Long-Term Debt to Total Capital now at 34.59.
Reflecting on the efficiency of the workforce at the company, Thermo Fisher Scientific Inc. [TMO] managed to generate an average of $79,688 per employee. Receivables Turnover for the company is 5.64 with a Total Asset Turnover recorded at a value of 0.51.Thermo Fisher Scientific Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.90 and a Current Ratio set at 2.50.
Earnings per share (EPS) analysis for Thermo Fisher Scientific Inc. [TMO] stock
With the latest financial reports released by the company, Thermo Fisher Scientific Inc. posted 3.89/share EPS, while the average EPS was predicted by analysts to be reported at 3.41/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 14.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TMO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Thermo Fisher Scientific Inc. go to 5.06%.
Thermo Fisher Scientific Inc. [TMO]: Insider Ownership positions
There are presently around $160,597 million, or 90.20% of TMO stock, in the hands of institutional investors. The top three institutional holders of TMO stocks are: VANGUARD GROUP INC with ownership of 30,852,079, which is approximately -0.469% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 29,311,819 shares of the stock with an approximate value of $13.63 billion in TMO stocks shares; and CAPITAL WORLD INVESTORS, currently with $7.78 billion in TMO stock with ownership of nearly 4.741% of the company’s market capitalization.
Positions in Thermo Fisher Scientific Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 977 institutional holders increased their position in Thermo Fisher Scientific Inc. [NYSE:TMO] by around 15,290,758 shares. Additionally, 879 investors decreased positions by around 17,064,906 shares, while 291 investors held positions by with 313,081,070 shares. The mentioned changes placed institutional holdings at 345,436,734 shares, according to the latest SEC report filing. TMO stock had 137 new institutional investments in for a total of 1,842,335 shares, while 110 institutional investors sold positions of 1,193,674 shares during the same period.